Cargando…
Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569706/ https://www.ncbi.nlm.nih.gov/pubmed/34746162 http://dx.doi.org/10.3389/fmed.2021.671215 |
_version_ | 1784594693643829248 |
---|---|
author | Li, Yingning Wang, Zhen Lian, Naqi Wang, Yuzun Zheng, Weiqiang Xie, Keliang |
author_facet | Li, Yingning Wang, Zhen Lian, Naqi Wang, Yuzun Zheng, Weiqiang Xie, Keliang |
author_sort | Li, Yingning |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19. |
format | Online Article Text |
id | pubmed-8569706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85697062021-11-06 Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 Li, Yingning Wang, Zhen Lian, Naqi Wang, Yuzun Zheng, Weiqiang Xie, Keliang Front Med (Lausanne) Medicine Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19. Frontiers Media S.A. 2021-10-22 /pmc/articles/PMC8569706/ /pubmed/34746162 http://dx.doi.org/10.3389/fmed.2021.671215 Text en Copyright © 2021 Li, Wang, Lian, Wang, Zheng and Xie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Li, Yingning Wang, Zhen Lian, Naqi Wang, Yuzun Zheng, Weiqiang Xie, Keliang Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title | Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title_full | Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title_fullStr | Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title_full_unstemmed | Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title_short | Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 |
title_sort | molecular hydrogen: a promising adjunctive strategy for the treatment of the covid-19 |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569706/ https://www.ncbi.nlm.nih.gov/pubmed/34746162 http://dx.doi.org/10.3389/fmed.2021.671215 |
work_keys_str_mv | AT liyingning molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 AT wangzhen molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 AT liannaqi molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 AT wangyuzun molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 AT zhengweiqiang molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 AT xiekeliang molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19 |